Back

Short- and long-term efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Atrial fibrillation ablation - Outcomes and predictors Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Abdul Shokor Parwani

German Heart Centre Berlin, Berlin (Germany)

5 More presentations in this session

Presentation thumbnail
Atrial fibrillation relapse after a single catheter ablation procedure - an up to 10 years follow-up analysis
Doctor J. Mesquita (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Longer duration of persistent atrial fibrillation episodes prior to catheter ablation is associated with lower freedom of atrial arrhythmias after catheter ablation
Doctor N. Naksuk (Omaha, US)
Abstract Slides
Presentation thumbnail
Long term outcome following mitral valve repair or replacement: the impact of concomitant atrial fibrillation treatment and sinus rhythm restoration.
Professor C. Muneretto (Brescia, IT)
Abstract Slides
Presentation thumbnail
The influence of gender on 1-year outcomes of patients undergoing primary AF ablation
Ms M. Middeldorp (Adelaide, AU)
Abstract Slides
Presentation thumbnail
Identification of predictors for atrial fibrillation-free survival after catheter ablation of persistent atrial fibrillation-results from a large prospective cohort
Doctor K. Koch-Buettner (Munich, DE)
Abstract Slides

Access the full session

Session thumbnail
Atrial fibrillation ablation - Outcomes and predictors

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources